Rotem Industries - Medical Imaging
Orit Maimon is an experienced human resources professional currently serving as the VP of Human Resources at Rotem Industries since May 2017. Previously, Orit held various roles at Nestlé, including Human Resources Manager and Human Resources Coordinator from January 2012 to April 2017. Orit began the career at Adam-Milo, taking on positions such as Diagnostician and overseeing assessment testing for candidates, as well as providing professional references for "cellcom" from 2006 to January 2012. Orit holds an MA in Organizational Consulting from the University of Haifa and a BA in Behavioral Science from Ben-Gurion University of the Negev.
This person is not in any teams
This person is not in any offices
Rotem Industries - Medical Imaging
Hi-tech company specializing in the development and commercialization of technologies from research centers and start-ups. Rotem markets its products worldwide and has subsidiaries in the USA and Germany. Main business areas are medical imaging, crystal manufacturing, radiation detection and renewable energy. Rotem Industries' Medical Imaging business is a world leader in consumables for PET imaging. Rotem develops, manufactures and supplies complete packages for the production of radiotracers: oxygen-18 enriched water, plastic cassettes, precursors and complete reagent kits for a range of synthesis modules. Rotem serves its customers through a global distribution network, and Rotem excels in uncompromising product quality coupled with a deep understanding of customer needs to ensure uniformly high production yields and unsurpassed quality. The passion for quality is driven by a team of highly skilled and dedicated professionals who recognize the critical role their products play in the PET radiotracer production chain. Rotem is very active in the development and production of consumables for new radiotracers under development. These projects benefit from our interdisciplinary expertise and direct market access, which is the result of years of direct, day-to-day, close collaboration with radiopharmaceutical companies worldwide.